Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Lenvatinib Radioactive iodine-refractory thyroid cancer"'
Autor:
Juan C. Galofré, Paula Jiménez-Fonseca, J. Santamaría Sandi, G. Riesco Eizaguirre, C. Zafón Llopis, T. Ramón y Cajal Asensio, J. M. Gómez Sáez, E. Navarro González, Jaume Capdevila, Enrique Grande
Publikováno v:
Clinical and Translational Oncology. 19:279-287
Thyroid cancer is the single most prevalent endocrine malignancy; differentiated thyroid cancer (DTC) accounts for more than 90 % of all malignancies and its incidence has been rising steadily. For more patients, surgical treatment, radioactive iodin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::582e5e8e7ae6bcda17a0d89b5fdf379e
https://doi.org/10.1007/s12094-016-1554-5
https://doi.org/10.1007/s12094-016-1554-5
Autor:
Capdevila, Jaume, Galofré, J. C., Grande, Enrique, Zafón Llopis, C., Ramón y Cajal Asensio, T., Navarro González, Elena, Jiménez-Fonseca, Paula, Santamaría Sandi, J., Gómez Sáez, J. M., Riesco-Eizaguirre, Garcilaso
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
Thyroid cancer is the single most prevalent endocrine malignancy; differentiated thyroid cancer (DTC) accounts for more than 90 % of all malignancies and its incidence has been rising steadily. For more patients, surgical treatment, radioactive iodin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::033e554e1f9c841305b4542dc552363d
http://hdl.handle.net/10261/198638
http://hdl.handle.net/10261/198638
